Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-18
DOI
10.1038/s41467-020-20664-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The bone marrow microenvironment at single-cell resolution
- (2019) Anastasia N. Tikhonova et al. NATURE
- Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease
- (2019) Jooho Chung et al. JOURNAL OF IMMUNOLOGY
- Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
- (2019) M. V. Giuli et al. Journal of Oncology
- Inducible knockout of ∆Np63 alters cell polarity and metabolism during pubertal mammary gland development
- (2019) Sushil Kumar et al. FEBS LETTERS
- Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis
- (2018) Anton Lennikov et al. ANGIOGENESIS
- Inhibition of HER2 Enriches for Jagged1-dependent Breast Cancer Stem Cells: Role for Membrane Jagged1
- (2018) Deep Shah et al. CLINICAL CANCER RESEARCH
- Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche
- (2018) Rumela Chakrabarti et al. SCIENCE
- The Notch Pathway in Breast Cancer Progression
- (2018) Emmanuel N. Kontomanolis et al. TheScientificWorldJOURNAL
- Role of the NFκB-signaling pathway in cancer
- (2018) Longzheng Xia et al. OncoTargets and Therapy
- The Notch Pathway in Breast Cancer Progression
- (2018) Emmanuel N. Kontomanolis et al. Scientific World Journal
- Inhibiting TRK Proteins in Clinical Cancer Therapy
- (2018) Allison Lange et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development
- (2018) Rajshekhar R. Giraddi et al. Cell Reports
- ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
- (2018) Sushil Kumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
- (2018) Sushil Kumar et al. ONCOGENE
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- Notch-out for breast cancer therapies
- (2017) Márcia Lamy et al. New Biotechnology
- Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
- (2017) Carmela Ricciardelli et al. Oncotarget
- Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma
- (2016) Susana Galli et al. AMERICAN JOURNAL OF PATHOLOGY
- Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
- (2016) Maria Cristina Rangel et al. BREAST CANCER RESEARCH AND TREATMENT
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
- (2016) Bernard Pereira et al. Nature Communications
- In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion
- (2016) Pulari U. Thangavelu et al. Clinical Epigenetics
- Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes through AP-1/microRNA-451 Mediated Regulation of MDR-1
- (2016) Jiayuan Huang et al. Molecular Therapy-Nucleic Acids
- Progress in adjuvant chemotherapy for breast cancer: an overview
- (2015) Jesus Anampa et al. BMC Medicine
- Identifying and targeting tumor-initiating cells in the treatment of breast cancer
- (2015) W. Wei et al. ENDOCRINE-RELATED CANCER
- IKK Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment
- (2015) Y. Kinose et al. MOLECULAR CANCER THERAPEUTICS
- Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
- (2015) Shany Koren et al. MOLECULAR CELL
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
- (2015) S Kumar et al. Cell Death & Disease
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Resveratrol Reduces the Hypoxia-Induced Resistance to Doxorubicin in Breast Cancer Cells
- (2014) Takakazu MITANI et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- NF-κB Signaling Is Required for XBP1 (Unspliced and Spliced)-Mediated Effects on Antiestrogen Responsiveness and Cell Fate Decisions in Breast Cancer
- (2014) Rong Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling
- (2014) Rumela Chakrabarti et al. NATURE CELL BIOLOGY
- Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling
- (2014) Silvia Park et al. Scientific Reports
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Elevated Expression of Notch1 Is Associated With Metastasis of Human Malignancies
- (2013) He Zhu et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Hypoxia, notch signalling and prostate cancer
- (2013) Laure Marignol et al. Nature Reviews Urology
- Notch inhibitors for cancer treatment
- (2013) Ingrid Espinoza et al. PHARMACOLOGY & THERAPEUTICS
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
- (2012) Rumela Chakrabarti et al. NATURE CELL BIOLOGY
- Dll1+ secretory progenitor cells revert to stem cells upon crypt damage
- (2012) Johan H. van Es et al. NATURE CELL BIOLOGY
- The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications
- (2011) Marco A. Velasco-Velázquez et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2
- (2011) James W. Antoon et al. CANCER BIOLOGY & THERAPY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer
- (2011) P. M. McGowan et al. MOLECULAR CANCER RESEARCH
- HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases
- (2010) Robert Klopfleisch et al. BMC Veterinary Research
- Breast Cancer Stem Cells: Something Out of Notching?
- (2010) H. Harrison et al. CANCER RESEARCH
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance
- (2010) Nathan Moore et al. Journal of Oncology
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of Delta-like 1 in the splenic non-hematopoietic cells is essential for marginal zone B cell development
- (2008) Yin Sheng et al. IMMUNOLOGY LETTERS
- Antiallergic and Anti-Inflammatory Effects of a Novel IκB Kinase β Inhibitor, IMD-0354, in a Mouse Model of Allergic Inflammation
- (2008) Akemi Sugita et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice
- (2008) Y. Moriyama et al. INTERNATIONAL IMMUNOLOGY
- Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
- (2008) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now